Two fictional examples
Both examples use a 12-month accounting period from 1 January to 31 December 2025. The companies are registered in England, have no connected companies and have qualifying UK R&D activity. Relevant costs have been paid. Each has £10,000 of relevant PAYE/NIC liabilities, giving a £50,000 cap: £20,000 + 300% × £10,000.
Assume both meet the other claim and going-concern conditions, have no other income or HMRC debts, and no enquiry or other restriction prevents payment. These are different companies, not a like-for-like promise about which scheme is better.
A company using merged RDEC
Company A has £100,000 of qualifying expenditure, £400,000 of total relevant expenditure and a £50,000 trading loss before the expenditure credit. Its R&D intensity is 25%; assume it has no entitlement to the ERIS grace period.
Scroll the table horizontally to see all columns.
A company using merged RDEC| Calculation | Working | Result |
|---|
| Gross expenditure credit | £100,000 × 20% | £20,000 |
|---|
| Trading loss after the taxable credit | £50,000 loss less £20,000 credit income | £30,000 loss |
|---|
| Current-period Corporation Tax offset | No taxable profits on the stated facts | £0 |
|---|
| Step 2 notional-tax restriction | £20,000 × 19% | (£3,800) |
|---|
| Amount remaining after step 2 | £20,000 − £3,800 | £16,200 |
|---|
| PAYE cap | £20,000 + 3 × £10,000 | £50,000 |
|---|
| Illustrative current cash payment | No further offsets or restrictions on the stated facts | £16,200 |
|---|
The £3,800 step 2 restriction is carried forward to discharge future Corporation Tax under the applicable rules; it is not described here as a separate cash payment. The company also retains a different loss position after recognising the taxable credit. The illustration is not a promise about its lifetime tax benefit.
A company that qualifies for ERIS
Company B is an eligible SME with £100,000 of qualifying expenditure, £300,000 of total relevant expenditure and a £50,000 unrelieved trading loss before the additional deduction. Its R&D intensity is £100,000 ÷ £300,000 = approximately 33.33%, above 30%.
Scroll the table horizontally to see all columns.
A company that qualifies for ERIS| Calculation | Working | Result |
|---|
| Additional deduction | £100,000 × 86% | £86,000 |
|---|
| Trading loss after additional deduction | £50,000 + £86,000 | £136,000 |
|---|
| Enhanced expenditure ceiling | £100,000 × 186% | £186,000 |
|---|
| Surrenderable loss | Lower of £136,000 and £186,000 | £136,000 |
|---|
| Payable credit before the cap | £136,000 × 14.5% | £19,720 |
|---|
| PAYE cap | £20,000 + 3 × £10,000 | £50,000 |
|---|
| Illustrative payable credit | Cap does not restrict the amount | £19,720 |
|---|
If Company B surrenders all £136,000, that surrendered loss is no longer available for later relief. The example shows why applying 14.5% to 186% of expenditure without checking the actual unrelieved loss can overstate the cash amount.
Both examples follow HMRC’s calculation guidance. A company eligible for ERIS may choose merged RDEC instead, but cannot claim both schemes on the same costs.